Neos Theraps Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NEOS THERAPS INC
NEOS THERAPS INC has three approved drugs.
There are seven US patents protecting NEOS THERAPS INC drugs.
Summary for Neos Theraps Inc
| US Patents: | 7 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Neos Theraps Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neos Theraps Inc | COTEMPLA XR-ODT | methylphenidate | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 205489-002 | Jun 19, 2017 | AB | RX | Yes | No | 9,089,496 | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| Neos Theraps Inc | COTEMPLA XR-ODT | methylphenidate | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 205489-001 | Jun 19, 2017 | AB | RX | Yes | No | 8,840,924 | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| Neos Theraps Inc | COTEMPLA XR-ODT | methylphenidate | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 205489-003 | Jun 19, 2017 | AB | RX | Yes | Yes | 9,072,680 | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| Neos Theraps Inc | ADZENYS ER | amphetamine | SUSPENSION, EXTENDED RELEASE;ORAL | 204325-001 | Sep 15, 2017 | DISCN | Yes | No | 9,017,731 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Neos Theraps Inc | HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX | chlorpheniramine polistirex; hydrocodone polistirex | SUSPENSION, EXTENDED RELEASE;ORAL | 091671-001 | Jun 29, 2012 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Neos Theraps Inc | COTEMPLA XR-ODT | methylphenidate | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 205489-002 | Jun 19, 2017 | AB | RX | Yes | No | 9,072,680 | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Neos Theraps Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Neos Theraps Inc | COTEMPLA XR-ODT | methylphenidate | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 205489-001 | Jun 19, 2017 | 8,840,924 | ⤷ Start Trial |
| Neos Theraps Inc | COTEMPLA XR-ODT | methylphenidate | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 205489-003 | Jun 19, 2017 | 8,840,924 | ⤷ Start Trial |
| Neos Theraps Inc | COTEMPLA XR-ODT | methylphenidate | TABLET, ORALLY DISINTEGRATING, EXTENDED RELEASE;ORAL | 205489-002 | Jun 19, 2017 | 8,840,924 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Neos Theraps Inc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2018085256 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2013003622 | ⤷ Start Trial |
| European Patent Office | 3585439 | ⤷ Start Trial |
| South Korea | 20190107655 | ⤷ Start Trial |
| Japan | 2020504763 | ⤷ Start Trial |
| Australia | 2017353921 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
